Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4130)
All Articles published online
|
Oct 21, 2008 (publication date) through Aug 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Su K, Chen F, Yan WM, Zeng QL, Xu L, Xi D, Pi B, Luo XP, Ning Q. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i39/5980.htm |
| Number | Citing Articles |
| 1 |
Yanling Liu, Li Xu, Qili Zeng, Jingli Wang, Ming Wang, Dong Xi, Xiaojing Wang, Daofeng Yang, Xiaoping Luo, Qin Ning. Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis. Liver International 2012; 32(10): 1585 doi: 10.1111/j.1478-3231.2012.02865.x
|
| 2 |
Wen-Zheng Qin, Quan-Lin Li, Wei-Feng Chen, Mei-Dong Xu, Yi-Qun Zhang, Yun-Shi Zhong, Li-Li Ma, Jian-Wei Hu, Ming-Yan Cai, Meng-Jiang He, Li-Qing Yao, Ping-Hong Zhou. Overexpression of fibrinogen-like protein 2 induces epithelial-to-mesenchymal transition and promotes tumor progression in colorectal carcinoma. Medical Oncology 2014; 31(9) doi: 10.1007/s12032-014-0181-7
|
| 3 |
Molly L. Jackson, Andrew R. Bond, Raimondo Ascione, Jason L. Johnson, Sarah J. George. FGL2/FcγRIIB Signalling Mediates Arterial Shear Stress-Mediated Endothelial Cell Apoptosis: Implications for Coronary Artery Bypass Vein Graft Pathogenesis. International Journal of Molecular Sciences 2024; 25(14): 7638 doi: 10.3390/ijms25147638
|
| 4 |
Ming Wang, Junhui Liu, Dong Xi, Xiaoping Luo, Qin Ning. Adenovirus‐mediated artificial microRNA against human fibrinogen like protein 2 inhibits hepatocellular carcinoma growth. The Journal of Gene Medicine 2016; 18(7): 102 doi: 10.1002/jgm.2883
|
| 5 |
Khatri Latha, Jun Yan, Yuhui Yang, Loyola V Gressot, Ling-Yuan Kong, Ganiraju Manyam, Ravesanker Ezhilarasan, Qianghu Wang, Erik P Sulman, R Eric Davis, Suyun Huang, Gregory N Fuller, Arvind Rao, Amy B Heimberger, Shulin Li, Ganesh Rao. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma. JNCI: Journal of the National Cancer Institute 2019; 111(3): 292 doi: 10.1093/jnci/djy107
|
| 6 |
Tie-Jiang Chen, Ming-Xia Ji, Zhi-Qiang Tao, Qing-Yang Fu, Kai Xiong, Bin Cheng. The relationship between serum fibrinogen-like protein 2 concentrations and 30-day mortality of patients with traumatic brain injury. Clinica Chimica Acta 2019; 489: 53 doi: 10.1016/j.cca.2018.11.033
|
| 7 |
Esther Rabizadeh, Izhack Cherny, Ofir Wolach, Shany Sherman, Natalia Binkovski, Alon Peretz, Doron Lederfein, Aida Inbal, Ari Waisman. Increased Activity of Cell Membrane-Associated Prothrombinase, Fibrinogen-Like Protein 2, in Peripheral Blood Mononuclear Cells of B-Cell Lymphoma Patients. PLoS ONE 2014; 9(10): e109648 doi: 10.1371/journal.pone.0109648
|
| 8 |
Jiemiao Hu, Jun Yan, Ganesh Rao, Khatri Latha, Willem W. Overwijk, Amy B. Heimberger, Shulin Li. The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications. International Reviews of Immunology 2014; : 1 doi: 10.3109/08830185.2014.956360
|
| 9 |
Qin Ning, Ting Wu, Hai-Bin Su, Ke Ma, Jun-Ying Qi, Ming Ni, Di Wu. Acute Exacerbation of Chronic Hepatitis B. 2019; : 371 doi: 10.1007/978-94-024-1603-9_5
|
| 10 |
Piyush B Madhamshettiwar, Stefan R Maetschke, Melissa J Davis, Antonio Reverter, Mark A Ragan. Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets. Genome Medicine 2012; 4(5): 41 doi: 10.1186/gm340
|
| 11 |
Ming Wang, Dong Xi, Qin Ning. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatology International 2017; 11(2): 171 doi: 10.1007/s12072-016-9779-5
|
| 12 |
Ming Tang, Xu Cao, Peng Li, Kun Zhang, You Li, Quan-you Zheng, Gui-qing Li, Jian Chen, Gui-lian Xu, Ke-qin Zhang. Increased expression of Fibrinogen-Like Protein 2 is associated with poor prognosis in patients with clear cell renal cell carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-13149-x
|
| 13 |
Corey L. Campbell, Aaron T. Phillips, Amber Rico, Amanda McGuire, Tawfik A. Aboellail, Sandra Quackenbush, Ken E. Olson, Tony Schountz. Involvement of Pro-Inflammatory Macrophages in Liver Pathology of Pirital Virus-Infected Syrian Hamsters. Viruses 2018; 10(5): 232 doi: 10.3390/v10050232
|
| 14 |
Jun Yan, Ling-Yuan Kong, Jiemiao Hu, Konrad Gabrusiewicz, Denada Dibra, Xueqing Xia, Amy B. Heimberger, Shulin Li. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas. JNCI: Journal of the National Cancer Institute 2015; 107(8) doi: 10.1093/jnci/djv137
|
| 15 |
T. Kawaguchi, T. Ide, M. Itou, M. Suetsugu, S. Yoshioka, M. Sakata, E. Taniguchi, T. Oriishi, S. Sumie, O. Tsuruta, M. Sata. Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review. Journal of Viral Hepatitis 2012; 19(2) doi: 10.1111/j.1365-2893.2011.01501.x
|
| 16 |
Weina Li, Meifang Han, Yong Li, Dan Chen, Xiaoping Luo, Qin Ning. Antiviral resistance mutations potentiate HBV surface antigen-induced transcription of hfgl2 prothrombinase gene. Biochemistry (Moscow) 2011; 76(9): 1043 doi: 10.1134/S0006297911090094
|
| 17 |
XIAOHUA YE, JIAPING HUAI, RENPIN CHEN, JIN DING, YANPING CHEN, ZHENZHAI CAI. Correlation of fibrinogen-like protein 2 with disease progression in patients with severe acute pancreatitis. Experimental and Therapeutic Medicine 2014; 7(1): 85 doi: 10.3892/etm.2013.1354
|
| 18 |
Hoang Van Tong, Nguyen Van Ba, Nghiem Xuan Hoan, Mai Thanh Binh, Dao Thanh Quyen, Ho Anh Son, Hoang Van Luong, Do Quyet, Christian G. Meyer, Le Huu Song, Nguyen Linh Toan, Thirumalaisamy P. Velavan. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3473-2
|
| 19 |
Esther Rabizadeh, Izhack Cherny, Doron Lederfein, Shany Sherman, Natalia Binkovsky, Yevgenia Rosenblat, Aida Inbal. The cell-membrane prothrombinase, fibrinogen-like protein 2, promotes angiogenesis and tumor development. Thrombosis Research 2015; 136(1): 118 doi: 10.1016/j.thromres.2014.11.023
|
| 20 |
Wen‐Bin Xu, Qian‐Hua Hu, Chan‐Ni Wu, Zhi‐Kun Fan, Zhang‐Fa Song. Serum soluble fibrinogen‐like protein 2 concentration predicts delirium after acute pancreatitis. Brain and Behavior 2019; 9(4) doi: 10.1002/brb3.1261
|
| 21 |
Ping Zhang, Fei Cao, Nian Xiong, Jinsha Huang, Tao Wang, Liang Shao. flg2 as a potential biomarker of acute cerebral ischemic-reperfusion injury. Microvascular Research 2015; 99: 36 doi: 10.1016/j.mvr.2015.02.003
|
| 22 |
Cheng Fan, Jue Wang, Chaoqin Mao, Wenzhu Li, Kun Liu, Zhaohui Wang. The FGL2 prothrombinase contributes to the pathological process of experimental pulmonary hypertension. Journal of Applied Physiology 2019; 127(6): 1677 doi: 10.1152/japplphysiol.00396.2019
|
| 23 |
Yu Liu, Hui Chen, Zhi-Ying Xu. Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report. Medicine 2023; 102(14): e33378 doi: 10.1097/MD.0000000000033378
|
| 24 |
Di Wu, Hongwu Wang, Weiming Yan, Tao Chen, Ming Wang, Meifang Han, Zeguang Wu, Xiaojing Wang, Guo Ai, Dong Xi, Guanxin Shen, Xiaoping Luo, Qin Ning. A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2. Immunologic Research 2016; 64(2): 518 doi: 10.1007/s12026-015-8727-0
|
| 25 |
Izhack Cherny, Pinhas Hasin, Lital Kalich Philosoph, Yael Shahal-Zimra, Ronit Gurion, Esther Rabizadeh, Samiullah Khan. Presence and activity of Fibrinogen like protein 2 in platelets. PLOS ONE 2023; 18(5): e0285735 doi: 10.1371/journal.pone.0285735
|
| 26 |
Xiaoying Yao, Yaying Song, Ze Wang, Shuwei Bai, Haojun Yu, Yishu Wang, Yangtai Guan. Proteinase-activated Receptor-1 Antagonist Attenuates Brain Injury via Regulation of FGL2 and TLR4 after Intracerebral Hemorrhage in Mice. Neuroscience 2022; 490: 193 doi: 10.1016/j.neuroscience.2022.02.012
|
| 27 |
Yuan Zhao, Zheng Xiang, Haoran Pan, Xielin Huang, Weizhen Chen, Zhiming Huang. FGL2 improves experimental colitis related to gut microbiota structure and bile acid metabolism by regulating macrophage autophagy and apoptosis. Heliyon 2024; 10(14): e34349 doi: 10.1016/j.heliyon.2024.e34349
|
| 28 |
Liang Shao, Yong Zhang, Aiqun Ma, Ping Zhang, Dayin Wu, Wenzhu Li, Jue Wang, Kun Liu, Zhaohui Wang. Atorvastatin preconditioning improves the forward blood flow in the no‐reflow rats. Fundamental & Clinical Pharmacology 2014; 28(1): 42 doi: 10.1111/j.1472-8206.2012.01074.x
|
| 29 |
Wen-Zhu Li, Jue Wang, Rui Long, Guan-Hua Su, Dinesh-Kumar Bukhory, Jing Dai, Nan Jin, Shi-Yuan Huang, Peng Jia, Ting Li, Chen Fan, Kun Liu, Zhaohui Wang, Lucia R. Languino. Novel Antibody against a Glutamic Acid-Rich Human Fibrinogen-Like Protein 2-Derived Peptide near Ser91 Inhibits hfgl2 Prothrombinase Activity. PLoS ONE 2014; 9(4): e94551 doi: 10.1371/journal.pone.0094551
|
| 30 |
Haijing Yu, Yang Liu, Jiaquan Huang, Hongwu Wang, Weiming Yan, Dong Xi, Guanxin Shen, Xiaoping Luo, Qin Ning. IL-33 protects murine viral fulminant hepatitis by targeting coagulation hallmark protein FGL2/fibroleukin expression. Molecular Immunology 2017; 87: 171 doi: 10.1016/j.molimm.2017.04.011
|
| 31 |
Yanling Liu, Sanpeng Xu, Fei Xiao, Yan Xiong, Xiaojin Wang, Sui Gao, Weiming Yan, Qin Ning. The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway. Biochemical and Biophysical Research Communications 2010; 396(2): 555 doi: 10.1016/j.bbrc.2010.04.145
|
| 32 |
Guangli Liu, Xintao Xu, Hui Geng, Jianchao Li, Shenshan Zou, Xin Li. FGA inhibits metastases and induces autophagic cell death in gastric cancer via inhibiting ITGA5 to regulate the FAK/ERK pathway. Tissue and Cell 2022; 76: 101767 doi: 10.1016/j.tice.2022.101767
|
| 33 |
Zitong Zhao, Lingyan Wang, Cheng Yang, Tian Zhao, Long Li, Linkun Hu, Duojiao Wu, Ruiming Rong, Ming Xu, Tongyu Zhu. Soluble FGL2 induced by tumor necrosis factor-α and interferon-γ in CD4+ T cells through MAPK pathway in human renal allograft acute rejection. Journal of Surgical Research 2013; 184(2): 1114 doi: 10.1016/j.jss.2013.04.011
|
| 34 |
Jiongming Chen, Lei Wu, Yongsheng Li. FGL1 and FGL2: emerging regulators of liver health and disease. Biomarker Research 2024; 12(1) doi: 10.1186/s40364-024-00601-0
|
| 35 |
S. Kõks, A. Velthut, A. Sarapik, S. Altmäe, E. Reinmaa, L.C. Schalkwyk, C. Fernandes, H.V. Lad, U. Soomets, Ü. Jaakma, A. Salumets. The differential transcriptome and ontology profiles of floating and cumulus granulosa cells in stimulated human antral follicles. MHR: Basic science of reproductive medicine 2010; 16(4): 229 doi: 10.1093/molehr/gap103
|
| 36 |
Hu Yang, Yang Xuefeng, Xiao Jianhua. Systematic review of the roles of interleukins in hepatocellular carcinoma. Clinica Chimica Acta 2020; 506: 33 doi: 10.1016/j.cca.2020.03.001
|
| 37 |
Xin Yuan, Ya Li, An Zhi Zhang, Chen Hao Jiang, Fan Ping Li, Yu Fang Xie, Jiang Fen Li, Wei Hua Liang, Hai Jun Zhang, Chun Xia Liu, Li Juan Pang, Xi Hua Shen, Feng Li, Jian Ming Hu. Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma. Aging 2021; 13(2): 2049 doi: 10.18632/aging.202201
|
| 38 |
Guanhua Su, Kun Liu, Yan Wang, Jue Wang, Xiaowei Li, Wenzhu Li, Yuhua Liao, Zhaohui Wang. Fibrinogen-like protein 2 expression correlates with microthrombosis in rats with type 2 diabetic nephropathy. Journal of Biomedical Research 2011; 25(2): 120 doi: 10.1016/S1674-8301(11)60015-8
|
| 39 |
Kristianne J. C. Galpin, Galaxia M. Rodriguez, Vincent Maranda, David P. Cook, Elizabeth Macdonald, Humaira Murshed, Shan Zhao, Curtis W. McCloskey, Andrzej Chruscinski, Gary A. Levy, Michele Ardolino, Barbara C. Vanderhyden. FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-51217-1
|
| 40 |
Zsuzsa Bagoly. Cancer and thrombosis: a fresh look at an old story. Thrombosis Research 2015; 136(1): 1 doi: 10.1016/j.thromres.2015.04.028
|